Latest DEF 14A proxy statements

Incannex Healthcare Inc. announces its Annual Meeting of Stockholders for December 18, 2025, to vote on director elections and auditor ratification.

Village Super Market, Inc. has filed a definitive proxy statement with the SEC.

Sonnet BioTherapeutics is set to merge with Hyperliquid Strategies Inc. (Pubco), transforming into a digital asset treasury company focused on HYPE tokens, with existing Sonnet shareholders receiving Pubco common stock and contingent value rights.

Soluna Holdings, Inc. urges shareholders to vote FOR proposals to increase authorized shares from 75 million to 375 million to fund future growth and strategic initiatives.

FactSet Research Systems Inc. has filed definitive additional materials for its proxy statement with the SEC.

Cross Country Healthcare, Inc. has filed a definitive proxy statement with the SEC under Section 14(a) of the Securities Exchange Act of 1934.

BILL Holdings, Inc. announces its 2025 Annual Meeting of Shareholders to vote on director elections, auditor ratification, and executive compensation.

Serina Therapeutics, Inc. filed an amendment to its definitive proxy statement, clarifying details for a stockholder vote on issuing common stock related to convertible notes and warrants.

Pixelworks, Inc. announces a special shareholder meeting to approve the sale of its Pixelworks Shanghai subsidiary for approximately $130 million, aiming to focus on its TrueCut Motion cinema business.

Datavault AI Inc. will hold its Annual Meeting to vote on electing directors, ratifying auditors, and significantly increasing authorized shares to facilitate a major equity issuance to Scilex Holding Company.

Nabors Energy Transition Corp. II proposes to indefinitely extend its existence to collect settlement payments from e2Companies LLC, terminating its SPAC mission and facing Nasdaq delisting.

Incannex Healthcare Inc. announced its 2025 Annual Meeting of Stockholders to be held on December 18, 2025, to elect directors and ratify its independent auditor.

Village Super Market, Inc. announced its 2025 Annual Shareholder Meeting will be held virtually on December 12, 2025, to elect nine directors and ratify KPMG LLP as independent auditors.

Enveric Biosciences, Inc. calls a special meeting to seek stockholder approval for a reverse stock split, an increase in authorized shares, and the issuance of shares related to a recent warrant inducement transaction.

FactSet Research Systems Inc. announces its 2025 Annual Meeting of Stockholders, featuring director elections, auditor ratification, executive compensation advisory vote, and key plan and charter amendments.

Maywood Acquisition Corp. is seeking shareholder approval to change its name to Inflection Point Acquisition Corp. V and amend its articles of association, reflecting a recent sponsor and management change.

New Horizon Aircraft Ltd. announces its 2025 Annual Meeting of Shareholders to vote on director elections, auditor appointment, and an Employee Stock Purchase Plan.

Airship AI Holdings, Inc. announces its 2025 Annual Meeting of Stockholders to be held virtually on December 11, 2025, seeking approval for director elections, auditor ratification, and an increase of 2,000,000 shares for its equity incentive plan.

PMGC Holdings Inc. announced its 2025 Annual Meeting agenda, revealing a combined 1:4,900 reverse stock split, a new $20 million dilutive equity line of credit, and ongoing related-party consulting agreements.

Cross Country Healthcare reports $1.3 billion revenue in 2024, maintains strong balance sheet, and anticipates Q4 2025 merger close with Aya Healthcare amidst industry challenges.

BILL Holdings, Inc. announced robust fiscal 2025 results, including 13% revenue growth and significant non-GAAP operating income, alongside strategic investments in AI and board refreshment.

Bolt Projects Holdings, Inc. is seeking stockholder approval for a convertible notes and warrants offering to Murchinson Ltd. to address working capital needs and repay debt.

FB Bancorp, Inc. announced its 2025 Annual Meeting of Stockholders to elect directors, approve a new equity incentive plan, and ratify its independent accounting firm.

Lixte Biotechnology Holdings, Inc. will hold its 2025 Annual Meeting to elect directors, ratify auditors, and vote on a significant increase to its 2020 Stock Incentive Plan, proposing to add 2.75 million shares for a total of 3.5 million.

STAAR Surgical Company has postponed its special meeting of stockholders to vote on the Alcon merger agreement until December 3, 2025, citing ongoing discussions.

Focus Universal Inc. stockholders approved a significant increase in authorized shares, a potential $250 million capital raise, and a reverse stock split to maintain Nasdaq listing.

TransCode Therapeutics amended its Series A and B Preferred Stock terms, clarifying conversion limits and removing delisting-triggered conversion rights, pending shareholder approval for a larger transaction.

Armlogi Holding Corp. announces its 2025 Annual Meeting to elect directors and ratify auditors, while reporting a net loss of $15.3 million for fiscal year 2025 despite revenue growth.

Novartis AG has agreed to acquire Avidity Biosciences' neuroscience pipeline and RNA-targeting platform for $12 billion, while Avidity's early-stage cardiology programs will be spun off into a new publicly traded company, SpinCo.

Novartis AG will acquire Avidity Biosciences for $72.00 per share in cash, valuing the company at $12.0 billion, while Avidity's early-stage cardiology programs will be spun off into a new publicly traded entity, SpinCo.